Aptinyx Inc reported $677K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Biogen BIIB:US $ 0.1M 0M
Cara Therapeutics CARA:US $ 50K 0
Daiichi Sankyo 4568:JP Y 50000M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M